Trial Profile
Small Particle Inhaled Steroids in Refractory Steroid-responsive Asthma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Ciclesonide (Primary)
- Indications Asthma
- Focus Pharmacodynamics
- Acronyms SPIRA
- 25 Jul 2013 Accrual to date is 75% according to United Kingdom Clinical Research Network record.
- 18 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
- 05 Jun 2013 Accrual to date is 72% according to United Kingdom Clinical Research Network record.